Cargando…
Pharmacological evaluation of novel 5-HT(3) receptor antagonist, QCM-13 (N-cyclohexyl-3-methoxyquinoxalin-2-carboxamide) as anti-anxiety agent in behavioral test battery
OBJECTIVE: In the last few decades, serotonin type-3 (5-HT(3)) receptor antagonists have been identified as potential targets for anxiety disorders. In preclinical studies, 5-HT(3) antagonists have shown promising antianxiety effects. In this study, a novel 5-HT(3) receptor antagonist, QCM-13(N-cycl...
Autores principales: | Gupta, Deepali, Radhakrishnan, Mahesh, Thangaraj, Devadoss, Kurhe, Yeshwant |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4399007/ https://www.ncbi.nlm.nih.gov/pubmed/25883513 http://dx.doi.org/10.4103/0975-7406.154429 |
Ejemplares similares
-
Antidepressant-like effect of a novel 5-HT(3) receptor antagonist N-(benzo[d] thiazol-2-yl)-3-ethoxyquinoxalin-2-carboxamide 6k using rodents behavioral battery tests
por: Kurhe, Yeshwant, et al.
Publicado: (2014) -
Anti-anxiety effect of a novel 5-HT(3) receptor antagonist N-(benzo[d]thiazol-2-yl)-3-ethoxyquinoxalin-2-carboxamide (6k) using battery tests for anxiety in mice
por: Kurhe, Yeshwant Vijay, et al.
Publicado: (2014) -
Anxiolytic-like effect of (4-benzylpiperazin-1-yl)(3-methoxyquinoxalin-2-yl)methanone (6g) in experimental mouse models of anxiety
por: Bhatt, Shvetank, et al.
Publicado: (2013) -
Antidepressant-like effect of novel 5-HT3 receptor antagonist N-n-butyl-3-ethoxyquinoxalin-2-carboxamide (6p): An approach using rodent behavioral antidepressant tests
por: Bhatt, Shvetank, et al.
Publicado: (2013) -
Role of Hypothalamic-pituitary-adrenal-axis in Affective Disorders: Anti-depressant and Anxiolytic Activity of Partial 5-HT1A Agonist in Adrenalectomised Rats
por: Gupta, Deepali, et al.
Publicado: (2013)